2'-(tert-Butyl(phenyl)phosphino)-N2,N2,N6,N6-tetramethyl-[1,1'-biphenyl]-2,6-diamine, 98%, 5g

4-BROMO-7-(TRIFLUOROMETHYL)-1H-INDAZOLE, 95%, 100mg

Ethyl 2-Benzylacetoacetate>97.0%(GC)5g

Pyridine-4-sulfonyl chloride hydrochloride, 95.0%, 250mg

2-Methyl-3-pentanone>98.0%(GC)5mL

3-bromo-5-iodo-2,4-dimethylpyridine, 95.0%, 500mg

2,4-Bis(4-(tert-butyl)phenyl)-6-chloro-1,3,5-triazine, 98%, 5g

Polyethylene Glycol Dimethacrylate (n=approx. 9) (stabilized with MEHQ)500g

6-Methyl-5-hepten-2-one>98.0%(GC)25mL

2-Amino-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one, 97%, 5g

Diisopentylamine, 97.0%, 1g

Ulixertinib, 10mg

4-(Trifluoromethyl)benzoic acid hydrazide, 95.0%, 5g